United States · Growth startup

Who invested in Acetylon Pharmaceuticals

6 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$151Mraised across 6 rounds since 2009, from 6 sources

$7.3MSeries A$2.0MSeries A$12MSeries B$15MSeries B$15MGrowth$100MGrowth
Latest round
Growth, $100MJul 2013
Step-upi
6.7×
Investors
2
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2010201120122013
$7.3MSeries A$2.0MSeries A$12MSeries B$15MSeries B$15MGrowth$100MGrowth
First round
Series A, $7.3M
Aug 2009
Biggest round
$100M
Growth · Jul 2013
Usual gap between rounds
7 months
the median of 5

The rounds

  1. Jul 2013
    Growth$100M1 returning

    Reported by bostinno.streetwise.co

  2. Feb 2012
    Growth$15M1 new

    Reported by finance.yahoo.com

  3. Jun 2011
    Series B$15M

    No investor was named in the report.

    Reported by masshightech.comSEC filing: $14M sold, first sale Feb 2011

  4. Feb 2011
    Series B$12M

    No investor was named in the report.

    Reported by masshightech.comSEC filing: $12M sold, first sale Feb 2011

  5. Jan 2010
    Series A$2.0M

    No investor was named in the report.

    Reported by finsmes.com

  6. Aug 2009
    Series A$7.3M1 new

    Reported by onbiovc.comSEC filing: $7.3M sold, first sale Jul 2009

Founders and team

From the SEC filings it signed: 2 on the team.

  • Marc A. CohenExecutive Officer, Directori
  • Walter A. OgierExecutive Officer, Directori

On the board, as filediBruce A. DowneyElena A. ProkupetsJames A. BradnerKenneth A. Anderson

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2009Series A2010Series B2011Series B2011Growth2012Growth2013CelgeneThe Kraft Group

Everyone who backed them

CelgeneGrowth equity2rounds
The Kraft GroupInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Acetylon Pharmaceuticals

Who invested in Acetylon Pharmaceuticals?

Acetylon Pharmaceuticals's investors include Celgene and The Kraft Group.

How much has Acetylon Pharmaceuticals raised?

Acetylon Pharmaceuticals has raised $151M across 6 rounds since 2009.

When did Acetylon Pharmaceuticals last raise?

Acetylon Pharmaceuticals's most recent round was a Growth of $100M in Jul 2013.

What was Acetylon Pharmaceuticals's biggest round?

Its most recent round, $100M in Jul 2013, is also its largest on record.

Who backed Acetylon Pharmaceuticals first?

Acetylon Pharmaceuticals's first round on record, in Aug 2009, was backed by The Kraft Group.

What stage is Acetylon Pharmaceuticals at?

Acetylon Pharmaceuticals's latest named round is a Growth, in Jul 2013.

Where is Acetylon Pharmaceuticals based?

Acetylon Pharmaceuticals is based in the United States.

Companies like Acetylon Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.